Literature DB >> 2349632

Preparation of IgA-deficient platelets.

E M Sloand1, S M Fox, S M Banks, H G Klein.   

Abstract

The IgA-deficient patient presents a difficult transfusion problem, particularly if he or she has previously been immunized and has formed IgA antibodies. Blood components from IgA-deficient donors may be used safely but are often not accessible to transfusion facilities. A satisfactory red cell component may be obtained by standard freezing and washing methods. There is no comparable platelet concentrate that uniformly affords protection against anti-IgA-mediated reactions. A method has been developed for the preparation of an IgA-deficient platelet concentrate by washing with citrate-buffered saline. Platelets prepared in this manner were transfused successfully to an IgA-deficient patient with a history of anaphylaxis related to transfusion. It was further demonstrated that the removal of IgA is enhanced if platelets are washed within 48 hours of collection. When platelets were stored for more than 48 hours, similar washing techniques resulted in significantly higher levels of IgA in the platelets washed with either buffered (p = 0.004) or unbuffered (p = 0.0002) saline. Platelets washed with unbuffered saline (pH 4.5-5.5) contained substantially more IgA than did platelets washed in a similar manner with citrate-buffered saline (pH 6.5-6.8) (p = 0.001).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2349632     DOI: 10.1046/j.1537-2995.1990.30490273440.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Long-term persistence of selective IgA deficiency in healthy adults.

Authors:  S Koskinen; H Tölö; M Hirvonen; J Koistinen
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

2.  Long-Term Treatment and Transfusion of Normal Blood Components Following Tolerance Induction in Patients with Anti-IgA Anaphylactic Reactions.

Authors:  Abdulgabar Salama; Romina Kardashi; Olga Arbach
Journal:  Transfus Med Hemother       Date:  2014-09-15       Impact factor: 3.747

3.  Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment.

Authors:  N Ahrens; C Höflich; S Bombard; H Lochs; H Kiesewetter; A Salama
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.